Clermont-Ferrand, 13 July 2011 - METabolic EXplorer, a green chemistry company that specializes in the development of bioprocesses for the production of chemical compounds used in a wide range of everyday products (textile fibres, paints, solvents, animal feed supplements, adhesives), today announced its turnover figure for the first half of 2011.
In the first half of 2011 METabolic EXplorer recorded no “turnover”. For the record, the Company’s turnover virtually exclusively comprises license income for the two products (Glycolic Acid and L-Methionine) developed in partnership with manufacturer Roquette.
As of June 30th, 2011, METabolic EXplorer, which is pursuing its usual strict management policy, had cash and equivalent of €34.3 million compared with €34.8 million as of March 31st, 2011.
Note on intellectual property: In parallel with the development launched in Malaysia and the ongoing discussions with a view to forming a first partnership, METabolic EXplorer is continuing to pursue its active policy of strengthening its intellectual property portfolio – a genuine strategic asset. As of end-June 2011, the Company has a portfolio of 379 patents, including 53 delivered in countries with strategic importance (Europe, North America and Asia). This portfolio breaks down into 63 families, including five new families filed in the first half of this year. By this time last year the company had filed 299 patents in 50 families.
-END-
About METabolic EXplorer - www.metabolic-explorer.com
METabolic EXplorer is a biological chemistry company which was incorporated in 1999. Its goal is to help industrial businesses deal with the heralded "end of oil", so that they can continue to manufacture but in a sustainable way.
Based on the tried and tested principle of industrial fermentation, METabolic Explorer's solutions circumvent the problems posed by today’s burdensome and expensive petrochemical processes via the use of a wide range of renewable, sustainable raw materials. By optimizing the metabolic yield of non-pathogenic bacteria in a contained, controlled environment, the company facilitates the production of chemical compounds used in a wide range of everyday goods (textile fibres, paints, solvents, plastics and animal feed).
METabolic EXplorer is currently focusing its alternative biological solutions on the production of five compounds that together have an estimated, annual, end-market value of €11 billion. The company's strategy will be implemented in two forms – either via own-account developments (ie, manufacturing plants) in geographically strategic regions, or via limited exclusivity industrial partnerships in the shape of joint ventures.
METabolic EXplorer, based in Clermont-Ferrand, France, is listed on EURONEXT PARIS (EURONEXT C, METEX) and features in CAC Small.
Get free FINANCIAL information on METabolic EXplorer by registering with
www.metabolic-explorer.com or www.actus-finance.com.
METabolic Explorer contacts
Media and shareholder contacts
ATTITUDE Corporate
Eric de Lambert
E-mail: edelambert@attitude-corporate.com
Tel.: +33 (0)1 4970 4341 / +33 (0)6 2529 0658
Investor and analyst contacts
Actus Finance
Jérôme Fabreguettes-Leib
E-mail: jfl@actus.fr
Tel.: +33 (0)1 7735 0436
This communication includes forward-looking information which is subject to risks and uncertainties. The potential development of the company could be substantially different from that anticipated in this press release because of the various risk factors which are described in the company’s Listing Prospectus.
